title: Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus.
authors.affiliation: Redwood Outcomes, Vancouver, BC, Canada.
authors.forename: K
authors.initials: K
authors.lastname: Thorlund
authors.affiliation: Redwood Outcomes, Vancouver, BC, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Siliman
authors.affiliation: Redwood Outcomes, Vancouver, BC, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Eapen
authors.affiliation: Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Lund
authors.affiliation: Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Palencia